We also invest in for-profit ventures that show potential to improve human well-being at scale.
Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.
Sherlock Biosciences
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Sherlock Biosciences to support the development of a diagnostic platform to identify any human virus present in a patient sample.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested $5 million in EicOsis, a startup developing an oral treatment for neuropathic and inflammatory pain.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested $5.4 million in VasoRX, a startup developing a new therapy for vascular diseases such as atherosclerosis that are among the leading causes of death in the developed world.